Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia
NCT01298609
Occipital Transcranial Direct Current Stimulation in Fibromyalgia
NCT00947622
Effect of Transcranial Static Magnetic Field Stimulation in Fibromyalgia Syndrome
NCT04836325
UHCDS a-tDCS + TE in Fibromyalgia Patients
NCT06169748
The Clinical Effect of Low-Intensity Electromagnetic Field Neurostimulation in Fibromyalgia Syndrome Patients
NCT01180244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Effective stimulation
Effective stimulation at sub-threshold level
Occipital nerve stimulation
Placebo stimulation
Stimulation at non-effective strength
Occipital nerve stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Occipital nerve stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimally treated with adequate trials during 3 months
* Insight of the patient in her disease and capable of understanding and signing an informed consent
Exclusion Criteria
* History of substance abuse, unless treated and in remission during 6 months
* Cardiac disease
* History of epileptic insults
* Psychiatric disorders with psychotic symptoms
* Pace maker / defibrillator
* Pregnancy
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital Antwerp
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dirk De Ridder, M.D., PhD.
Role: STUDY_CHAIR
University Hospital, Antwerp
Mark Plazier, M.D.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Antwerp
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Antwerp
Edegem, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ahmed S, Plazier M, Ost J, Stassijns G, Deleye S, Ceyssens S, Dupont P, Stroobants S, Staelens S, De Ridder D, Vanneste S. The effect of occipital nerve field stimulation on the descending pain pathway in patients with fibromyalgia: a water PET and EEG imaging study. BMC Neurol. 2018 Nov 12;18(1):191. doi: 10.1186/s12883-018-1190-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMS_ONS_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.